How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 6, 2007, Pages 788-793

  Amarapurkar, Deepak N ^a,g   Hashimoto, Estsuko ^b   Lesmana, Laurentius A ^c   Sollano, José D ^d   Chen, Pei Jer ^e   Goh, Khean Lee ^f  

^a BOMBAY HOSPITAL   (India)

^b GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

^c UNIVERSITY OF INDONESIA   (Indonesia)

^d UNIVERSITY OF SANTO TOMAS   (Philippines)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f UNIVERSITY OF MALAYA   (Malaysia)

^g Plot No 947 950   (India)

Author keywords

Fatty liver disease; Non alcoholic

Indexed keywords

GLUCOSE;

ABDOMINAL RADIOGRAPHY; ALCOHOL CONSUMPTION; ASIA; CHINA; CHRONIC LIVER DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; INDIA; INDONESIA; INSULIN RESISTANCE; JAPAN; KOREA; LIVER BIOPSY; MALAYSIA; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGAPORE; SRI LANKA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 84984562986     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05042.x     Document Type: Review

References (57)

1. Farrell GC, Chitturi S, Lau GKK, Sollano J, the Asia-Pacific Working Party on Non-Alcoholic Fatty Liver Disease (NAFLD). Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region. Executive Summary. J. Gastroenterol. Hepatol. 2007 22 : 775 7.
2. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from Steatosis to cirrhosis. Hepatology 2006 43 (Suppl. 1 S99 112.
3. Angulo P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002 16 : 1221 31.
4. Chitturi S, Abeygunasekera S, Farrell GC et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002 35 : 373 9.
5. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003 37 : 1202 19.
6. Yoon KH, Lee JH, Kim JW et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006 368 : 1681 8.
7. Gore RM. Diffuse liver disease. In : Gore RM, Levine MS, Laufer I, eds. Textbook of Gastrointestinal Radiology. Philadelphia : Saunders, 1994 1968 2017.
8. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J. Exp. Med. 1983 139 : 43 50.
9. Fusamoto H, Suzuki K, Hayashi N et al. Obesity and liver disease: evaluation of fatty infiltration of the liver using ultrasonic attenuation. J. Nutr. Sci. Vitaminol. Tokyo 1991 37 (Suppl. S71 7.
10. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology 2005 41 : 1313 21.
11. McCullough AJ. The epidemiology and risk factors of NASH. In : Farrell GC, George J, de la M Hall P, McCullough AJ, eds. Fatty Liver Disease: NASH and Related Disorders. Malden, MA : Blackwell Publishing, 2005 23 37.
12. Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004 40 : 1387 95.
13. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002 122 : 1649 57.
14. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 2003 98 : 960 7.
15. Ruhl CE, Everhart JF. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003 124 : 71 9.
16. Amarapurkar DN, Patel ND. Clinical spectrum of non-alcoholic steatohepatitis with normal aminotransferase values. Trop Gastroenterol. 2004 25 : 132 4.
17. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GKK, Sollano JD, the Asia-Pacific Working Party on NAFLD. Non-alcoholic fatty liver disease in the Asia-Pacific region: Definitions and overview of proposed guidelines. J. Gastroenterol, Hepatol. 2007 22 : 778 87.
18. Hamaguchi M, Kojima T, Takeda N et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 2005 143 : 72208.
19. Fan JG, Zhu J, Li XJ et al. Fatty liver and the metabolic syndrome among Shanghai adults. J. Gastroenterol. Hepatol. 2005 20 : 1825 32.
20. McCullough AJ. Thiazolidinediones for nonalcoholic steatohepatitis - promising but not ready for prime time. N. Engl. J. Med. 2006 355 : 2361 3.
21. Weston SR, Leyden W, Murphy R et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005 41 : 372 9.
22. Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region. J. Gastroenterol. Hepatol. 2003 18 : 124 38.
23. Chitturi S, Farrell GC, George JS. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? J. Gastroenterol. Hepatol. 2004 19 : 368 74.
24. Park HS, Kim BI, Yun WJ, Kim JW et al. Insulin resistance and C reactive protein as independent risk factors for non alcoholic fatty liver disease in non-obese Asian men. J. Gastroenterol. Hepatol. 2004 19 : 694 8.
25. Nomura H, Kashiwaqi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn. J. Med. 1988 27 : 142 9.
26. Oshibuchi M, Nishi F, Sato M et al. Frequency of abnormalities detected by abdominal ultrasound amongst Japanese adults. J. Gastroenterol. Hepatol. 1991 6 : 165 8.
27. Ikai E, Ishizaki M, Suzuki Y, Ishida M, Noborizaka Y, Yamada Y. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people. J. Hum. Hypertens. 1995 9 : 101 5.
28. Yano E, Tagawa K, Yamoka K et al. Test validity of period liver function tests in a population of Japanese male bank employees. J. Clin. Epdemiol. 2001 54 : 945 51.
29. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJY, Chutaputti A, the Asia-Pacific Working Party for NAFLD. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific J. Gastroenterol. Hepatol. 2007 22 : 794 800.
30. Omagari K, Kadokawa Y, Masuda J et al. Fatty liver in non-alcoholic non-overweight Japanese adults. Incidence and clinical characteristics. J. Gastroenterol. Hepatol. 2002 17 : 1098 105.
31. Jimba S, Nakagami T, Takahashi M et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet. Med. 2005 22 : 1141 5.
32. Kojima S, Watanabe N, Numata M et al. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J. Gastroenterol. 2003 38 : 954 61.
33. Shen L, Fan JG, Shao Y et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai an epidemiological survey. World J. Gastroenterol. 2003 9 : 1106 10.
34. Fan JG, Zhu J, Li XJ et al. Prevalence of, and risk factors for, fatty liver in a general population of Shanghai, China. J. Hepatol. 2005 43 : 508 14.
35. Fan JG, Li F, Cai XB et al. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J. Gastroenterol. Hepatol. 2007 22 : 663 8.
36. Chen QK, Chen HY, Huang KH et al. Clinical features and risk factors of patients with fatty liver in Guangzhou area. World J. Gastoenterol. 2004 15 : 899 902.
37. Park SH, Jeon WK, Kim SH et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 2006 21 : 138 43.
38. Duseja A, Das A, Das R, Dhiman R, Chawla Y. Nonalcoholic steatohepatitis: our experience. Indian J. Gastroenterol. 2004 23 (Suppl. 1 S25.
39. Agarwal SR, Malhotra V, Sakhuja P, Sarin S. Clinical biochemical and histological profile of nonalcoholic steatohepatitis. Indian J. Gastroenterol. 2001 20 : 183 6.
40. Madan K, Batra Y, Panda S et al. Role of polymerase chain reaction and liver biopsy in the evaluation of patients with asymptomatic transaminitis. Implications in diagnostic approach. J. Gastroenterol. Hepatol. 2004 20 : 1291 9.
41. Chen CH, Huang MH, Yang JC et al. Prevalence and risk factors of non-alcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of non-alcoholic fatty liver disease in non-obese adults. J. Clin. Gastroenterol. 2006 40 : 745 52.
42. Lin TJ, Lin CL, Wang CS, Liu SO, Liao LY. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan. World J. Gastroenterol. 2005 11 : 3905 8.
43. Hasan I, Gani RA, Machmud R et al. Prevalence and risk factors for nonalcoholic fatty liver in Indonesia. J. Gastroenterol. Hepatol. 2002 17 (Suppl. S154.
44. Yiu DC, Leung NW. Epidemiological study: nonalcoholic fatty liver disease in Hong Kong Chinese. Hepatology 2004 40 (Suppl. 1 582A.
45. Wong VW, Hui AY, Tsang SW et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2006 4 : 1154 61.
46. Duseja A, Chawla Y. Nonalcoholic fatty liver disease in India. How Much? How Soon. Trop Gastoenterol. 2005 26 : 1 3.
47. Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J. Clin. Endocrinol. Metab. 2001 86 : 5366 71.
48. Yajnik CS, Fall CH, Coyaji KJ et al. Neonatal anthropometry: the thin fat Indian baby. The Pune maternal nutrition study. Int. J. Obes. Relat. Metab. Disord. 2003 27 : 173 80.
49. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004 27 : 1182 6.
50. Malik A, Cheah PL, Hilmi I, Chan SP, Goh KL. Non-alcoholic fatty liver disease in Malaysia: a demographic, anthropometric, metabolic and histological study. J. Dig. Dis. 2007 8 : 58 64.
51. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Curr. Sci. 2002 83 : 1483 96.
52. Mohan V, Deepa M, Deepa R et al. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India: the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 2006 49 : 1175 8.
53. Duseja A, Das A, Das R et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig. Dis. Sci. 2007 (in press).
54. De Hewavisenthi SJ, Dassanayake AS, De Silva HJ. Clinical, biochemical and histological characteristics of a Sri Lankan population of non-alcoholic steatohepatitis (NASH) patients. Ceylon Med. J. 2005 50 : 133 6.
55. Gupte P, Amarapurkar D, Agal S et al. Nonalcoholic steatohepatitis in type 2 diabetes mellitus. J. Gastroenterol. Hepatol. 2004 19 : 854 8.
56. Amarapurkar DN, Das HS. Chronic liver disease in diabetes mellitus. Trop Gastroenterol. 2002 23 : 3 5.
57. Duseaja A, Nanda M, Das A, Das R, Bhansali A, Chawla Y. Prevalence of obesity, diabetes mellitus and hyperlipidemia in patients with cryptogenic liver cirrhosis. Trop Gastoenterol. 2004 25 : 15 17.